Notes for Authors
Editor
USA, Canada and South America
Barry R. Goldspiel, PharmD
Associate Editors
Europe, Scandinavia, and Africa
Graham J. Sewell, PhD
Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer and is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP).
TYPES OF WORK CONSIDERED
Manuscripts are considered for publication with the understanding that they have not been published previously and are not under consideration by another publication. The following types of work will be considered:
Review Articles. Comprehensive and critical reviews of drug use in cancer patient care. For medication review articles please include introduction, pharmacology, pharmacokinetics/ pharmacodynamics, therapeutic use, clinical use controversies, product description (cost, special preparation and/or administrative considerations), and perspectives on use (summary paragraph including how this drug fits into current practice). For disease and supportive care management reviews include introduction, epidemiology, etiology, pathophysiology, patient presentation, common staging systems used (for malignancy treatment reviews), treatment (include surgery, radiation, but focus on drug therapy aspects), and summary. It is highly desirable to include a flow-diagram treatment algorithm to summarize disease management.
Original Research Articles. Articles should include a clear statement of purpose; a brief historical review; and a description of the methods, procedures, subjects used, statistical analysis, results, discussion, and conclusions (with clinical implications). For research involving human subjects, a statement must be included to assure that the principles set forth in the Helsinki Declaration of 1975, revised in 1983, were followed or that approval from a local or regional committee on human investigation was obtained. A statement must also be included attesting that informed consent was obtained from each subject or the subject's guardian.
Practice Guidelines. Institutional policies on medication use with outcome indicators.
Practice Issues. Reports of innovative services, policies, or outcome measure tools.
Case Reports. Include an introduction justifying the case report, the case description, and discussion.
Letters to the Editor. Brief comments on articles published in the Journal or other information of interest to our readers.
Editorials/ Commentaries. Expression of opinions about controversial therapeutic areas or comments about practice-related issues are encouraged.
Manuscript submission
The Journal of Oncology and Pharmacy Practice has a fully web-based system for the submission and review of manuscripts. All submissions should be made online at the Journal of Oncology Pharmacy Practice http:/mc.manuscriptcentral.com/jopp
Note: Online submission and review of manuscripts is now mandatory for all types of papers.
New User Account
Please log onto the website. If you are a new user, you will first need to create an account. Follow the instructions and please ensure to enter a current and correct email address. Creating your account is a three-step process that takes a matter of minutes to set up. When you have finished, your User ID and password is sent via email immediately. Please edit your user ID and password to something more memorable by selecting 'edit account' at the top of the screen. If you have already created an account but have forgotten your details type your email address in the 'Password Help' to receive an emailed reminder. Full instructions for uploading the manuscript are provided on the website.
New Submission
Submissions should be made by logging in and selecting the Author Center and the 'Click here to Submit a New Manuscript' option. Follow the instructions on each page, clicking the 'Next' button on each screen to save your work and advance to the next screen. If at any stage you have any questions or require the user guide, please use the 'Get Help Now' button at the top right of every screen. Further help is available through ScholarOne's® Manuscript CentralTM customer support at +1 434 817 2040 x 167.
To upload your files, click on the 'Browse' button and locate the file on your computer. Select the designation of each file (i.e. main document, submission form, figure) in the drop down next to the browse button. When you have selected all files you wish to upload, click the 'Upload Files' button
Review your submission (in both PDF and HTML formats) and then click the Submit button
You may suspend a submission at any point before clicking the Submit button and save it to submit later. After submission, you will receive a confirmation e-mail. You can also log back into your author centre at any time to check the status of your manuscript.
Please ensure that you submit editable/source files only (Microsoft Word or RTF) and that your document does not include page numbers; the Journal of Oncology and Pharmacy SAGETRACK system will generate them for you, and then automatically convert your manuscript to PDF for peer review. Furthermore, it is imperative that authors remove from their submissions any information that will identify them or their affiliations to reviewers. All correspondence, including notification of the Editor's decision and requests for revisions, will be by email.
If you would like to discuss your paper prior to submission, or seek advice on the submission process please contact the Managing Editor, Barry R. Goldspiel, at the following email address:
bgoldspiel@verizon.net.
Submitting a Revised Submission
Authors submitting revised manuscripts should follow the instructions above to submit through the SAGETRACK system. To create a revision, go to the 'Manuscripts with Decisions' option in your Author Dashboard and select 'create a revision in the 'Action' column. Authors of all revised submissions should, when prompted, provide information explaining the changes in your manuscript. As this will be provided to reviewers, it is important that authors do not identify themselves in these responses.
----------------------------------------------------------------------------------------------------
MANUSCRIPT PREPARATION
Journal of Oncology Pharmacy Practice encourages all authors to comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as per the International Committee of Medical Journal Editors http:/www.icmje.org/index.html.
All manuscripts should be typed, double-spaced on one side of the paper only. An original and three copies, each accompanied by artwork, should be submitted.
Title Page. In addition to the title, this page should include the full name, highest academic degree obtained, and affiliation for each author. Also indicate which author should be the corresponding author and provide a full address and phone and fax numbers. Please include a running title limited to 50 characters and provide up to 6 key words applicable to the content of the manuscript.
Abstract. Structured abstracts (less than 250 words) should be prepared for all review and original research articles. Guidelines for structured abstracts can be found in Annals of Internal Medicine (1990; 113:69-76) or JAMA (1991; 266:42-43) or obtained from one of the editors.
Text. For style information and lists of standard abbreviations, consult the American Medical Association Manual of Style, 8th ed. (Baltimore, MD, Williams & Wilkins, 1989). Use metric units throughout the manuscript. The first time an abbreviation appears, it should be preceded by the words for which it stands.
References and Notes. References and notes should be numbered sequentially as they appear in the text, tables, and figures, and they should be compiled at the end of the article in the order of text citation. List a reference only one time. Abbreviations for titles of periodicals should conform to those used in the latest edition of Index Medicus. References should include authors' last names and initials, article title, journal, volume, page range, and year. Include the city and publisher's name for books. For further information, consult the American Medical Association Manual of Style.
Examples
1. Sewell GJ, Allsopp M, Collinson MP, et al. Stability studies on admixtures of 5-fluorouracil with heparin for administration in continuous infusion regimens. J Clin Pharm Ther. 1992; 52:6229-6236.
2. Goldspiel BR, Kuhn JG. Prostate cancer. In DiPiro JT, Talbert RI, Hayes, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 2nd Ed. Norwalk, Conn: Appleton & Lange; 1993: 1968-1981.
Tables. These should be labeled sequentially as Table 1, Table 2, etc. Each table should be typed on a separate page, numbered, titled, and cited in the text. References to table footnotes should be made by means of Arabic numerals.
Figures. Photographs and line drawings should also be labeled sequentially, numbered, and cited in the text. Photographs should be professionally prepared glossy prints. Line drawings should be black ink on white paper. The author's name should appear on the reverse side of each figure. Symbols, lettering, and numbering should be clear and large enough to be legible after the figure has been reduced. Figure legends should be typewritten (double-spaced) on a separate sheet.
Permissions. Authors are responsible for obtaining permission from the author and publisher for the use of quotes, illustrations, tables, and other materials taken from previously published works not in the public domain. The letters of permission should accompany the manuscript. The original source should be mentioned in the figure caption or table footnote.
Covering letter. Authors should provide in a covering letter the name, address, email, telephone and fax numbers of the corresponding author. Authors are encouraged to suggest the names of possible reviewers and to indicate the names of individuals who may not be able to provide an unbiased review.
Conflict of interest. Authors should describe any affiliations or financial arrangements with any company whose product appears prominently in the manuscript or with any company making a competing product. Such information will be kept in confidence while the paper is under review and will not influence the editorial decision. If the article is accepted for publication, the editor will discuss with the author the manner in which this information will be communicated to the reader. Journal of Oncology Pharmacy Practice abides by the Uniform Requirements for Manuscripts Submitted to Biomedical Journals outlined by the International Committee of Medical Journal Editors. See: http:/www.icmje.org/index.html
Submitting Computer Disks for ACCEPTED Manuscripts. To help expedite processing, Journal of Oncology Pharmacy Practice encourages the submission of accepted articles on computer diskettes. All diskettes must be accompanied by the original and one paper copy of the manuscript. Label diskettes with the following information: (1) author's name, (2) article title, and (3) software and hardware used. Diskettes (either 3.5 or 5.25 inch) may be produced on IBM, IBM-compatible, Apple, or Wang computers. Authors using Apple computers should not use the "Fast Save" option.
MANUSCRIPT SUBMISSION
Please prepare articles as described above and send to one of the editors according to region:
EDITOR
USA, Canada, and South America
Barry R. Goldspiel, PharmD
Bethesda, MD, USA
Tel: +1 301 496 4363
Fax: +1 301 496 0210
Email: bgoldspiel@verizon.net.
ASSOCIATE EDITORS
Europe, Scandinavia, and Africa
Graham J. Sewell, PhD
School of Health Professions
University of Plymouth
Peninsula Allied Health Centre, SF20
Derriford Road
Plymouth PL6 8BH
UK
Tel: +44 (0) 1752 588817
Email: gjsewell@plymouth.ac.uk
Pacific Rim: Australia, New Zealand, and Asia
Proofing. The author will have the opportunity to review and approve page proofs of an accepted article before it is published. To be included, all corrections must be kept to a minimum and returned by the deadline provided. The publisher reserves the right to charge authors for corrections in excess of 10%.
Reprints. Reprints may be ordered at any time, before or after publication of the article, using the reprint order form enclosed with the galley proofs.
Access to 25 free e-prints will be provided; the corresponding author will receive one complimentary copy of the journal for each contributor.
SAGE Open:
If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Open upon payment of a publication fee. Manuscript submission and refereeing procedure is unchanged, but on acceptance of your article you will be asked to let SAGE know directly if you are choosing SAGE Open. For further information please visit http:/www.sagepub.co.uk/sageopen.sp
English Language Editing Services: Please click here for information on professional English language editing services recommended by SAGE.
